Value-Based Healthcare Market Size, Trends and Insights By Model (Accountable Care Organization, Patient-Centered Medical Home, Pay for Performance, Bundled Payments), By Deployment Type (Cloud, On-premises), By End User (Hospitals, Clinics, Insurance Companies, Government, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Cerner Corporation
- McKesson Corporation
- Siemens Healthier
- UnitedHealth Group
- Philips Healthcare
- Others
Reports Description
Global Value-Based Healthcare Market was valued at USD 3.9 Billion in 2023 and is expected to reach USD 20.5 Billion by 2032, at a CAGR of 7.5% during the forecast period 2023 – 2032.
Value-based healthcare (VBHC) is a healthcare delivery approach that aims to provide the highest possible results for patients while minimizing total care costs. It stresses the value of healthcare services rather than the quantity of treatments offered.
This strategy entails monitoring results that are important to patients, including gains in health, quality of life, and satisfaction, and then linking payment and incentives with those findings.
Value-Based Healthcare Market: Growth Factors
Increasing demand for high-quality health treatment
The growing need for high-quality healthcare is a major driving force behind the value-based healthcare market’s expansion. Patients are increasingly searching for healthcare solutions that provide better results and experiences, fuelling the trend toward value-based care.
Providers are incentivized to use this strategy to remain competitive and satisfy patient expectations. Value-based healthcare promotes the use of cutting-edge technology, data analytics, and collaborative care models to maximize resource usage and patient outcomes.
Furthermore, it promotes preventative care programs and patient involvement tactics, resulting in improved demographic health management. For instance, to achieve the intended results, high-quality health systems require strong governance and finance, as well as rules to control providers.
The proportion of U.S. adults who reported having any therapy for their mental health during the last 12 months increased from 19.2% in 2019 to 20.3% in 2020, and then to 21.6% in 2021.
Heightened demand for remote patient monitoring
Increased demand for remote patient monitoring (RPM) is a major factor driving the value-based healthcare market’s growth. RPM enables healthcare practitioners to remotely monitor patients’ vital signs, symptoms, and other health indicators in real time, even outside of typical clinical settings.
This allows for early diagnosis of health concerns, proactive intervention, and individualized treatment plans adapted to each patient’s specific requirements, eventually leading to better health outcomes and lower healthcare expenditures.
Using RPM technology, healthcare providers may transition from the old fee-for-service model to value-based care, in which compensation is dependent on the quality and efficacy of treatment supplied rather than the number of services offered.
For instance, The AJ Hospital and Research Centre have implemented Dozee’s innovative Al-based contactless and continuous remote patient monitoring (RPM) and early warning system (EWS).
Dozee’s early warning system (EWS) monitors critical parameter trends and informs healthcare personnel of early signs of clinical deterioration, allowing for appropriate medical intervention. Dozee employs Al-based Ballistocardiography (BCG) for contactless blood pressure tracking.
Value-Based Healthcare Market: Restraints
Balancing reimbursement and payment mechanisms
Due to their historical emphasis on fee-for-service models, payment and billing techniques sometimes impede the value-based healthcare market. In such structures, healthcare practitioners are compensated primarily on the number of services provided rather than the quality or outcomes obtained.
This provides an incentive for clinicians to pursue preventative care, patient outcomes, and cost efficiency. Value-based healthcare, on the other hand, focuses on providing high-quality treatment at reduced costs, aligning incentives with patient results.
Nonetheless, moving to value-based models necessitates considerable changes in reimbursement and payment systems, which can be complicated to implement. Furthermore, medical professionals may encounter financial challenges throughout the transition phase if payment structures fail to appropriately support value-based care activities.
Value-Based Healthcare Market: Opportunities
Growing significance of healthcare IT services
The rising importance of healthcare IT services propels the value-based healthcare market by improving efficiency, quality, and patient outcomes. IT solutions make it easier to gather, analyze, and use massive volumes of healthcare data, allowing providers to come up with more informed choices and allocate resources more efficiently.
Healthcare IT services use electronic health records (EHRs), telemedicine, and health information exchanges (HIEs) to streamline interaction between stakeholders, eliminate medical mistakes, and enhance care coordination.
Furthermore, analytics technologies assist in identifying patterns, predicting patient requirements, and personalizing treatments, all of which correspond with the value-based care goals of delivering better results at reduced costs.
Furthermore, IT infrastructure enables remote monitoring, patient involvement, and population health management, which promotes preventative care and lowers hospital readmission rates. As healthcare systems worldwide shift to value-based models that favor quality over volume, the integration of strong IT solutions becoming ever more essential for delivering long-term gains in healthcare delivery and results.
Value-Based Healthcare Market: Segmentation Analysis
Global Value-Based Healthcare market is segmented by models, deployment type, end user and region. Based on the model, the market is classified into accountable care organizations, patient-centered medical homes, pay performance and bundled payments.
Accountable care organizations dominated the market in 2022 with a market share of 45% and are expected to keep their dominance during the forecast period 2024-2032. Accountable care organizations (ACOs) play an important role in accelerating the shift to value-based healthcare by encouraging collaboration among healthcare providers and prioritizing positive results above several treatments.
ACOs seek to improve patient outcomes while controlling healthcare costs by promoting coordinated care and cost-effective practices.
ACOs incentivize healthcare providers to offer efficient, preventative, and patient-centered care via mechanisms such as shared savings agreements and risk-sharing models. Initiatives including care coordination, chronic illness management, and a focus on preventative measures can all help to reduce the need for costly treatments.
In addition, ACOs use data analytics and technology to discover improvement opportunities and enhance care delivery operations. This change to value-based treatment mainly improves patient experiences and outcomes, while it also helps to control costs and foster sustainability in healthcare systems, eventually driving the creation of a more effective and patient-centric healthcare paradigm.
Based on deployment type, the market is classified into cloud and on-premises. The cloud segment dominated the market in 2022 with a market share of 60% and is expected to keep its dominance during the forecast period 2024-2032.
Cloud technology is transforming value-based health care by improving accessibility to information, connectivity, and analytics capabilities. Cloud-based services provide a centralized platform for securely storing large volumes of patient data, allowing healthcare practitioners to access it in real-time from any location. This enables seamless cooperation among healthcare providers, resulting in more informed decisions and better patient outcomes.
Furthermore, cloud computing allows sophisticated analytics and machine learning algorithms to extract useful insights from large healthcare databases, allowing doctors to discover trends, forecast outcomes, and tailor treatment strategies.
Cloud-based platforms also make it easier to integrate disparate healthcare systems and apps, enabling transparency and data interchange across several healthcare settings. Cloud technology improves the efficiency and efficacy of value-based healthcare delivery by simplifying processes, lowering costs, and allowing data-driven decision-making.
Based on end user, the market is classified into hospitals, clinics, insurance companies, government and others. The hospital’s segment dominated the market in 2022 with a market share of 45% and is expected to keep its dominance during the forecast period 2024-2032.
Hospitals play a critical role in pushing the value-based healthcare industry by emphasizing results, performance, and patient happiness. They use care coordination tactics to facilitate smooth transitions across medical venues, decreasing duplication and increasing the patient experience.
Hospitals utilize technology to make data-driven decisions, promote evidence-based practices, and reduce medical mistakes. Hospitals also engage in preventative care efforts and population health management, to reduce the need for costly treatments by detecting and managing chronic illnesses early on.
Furthermore, hospitals work with payers and providers to develop value-based payment models that prioritize positive results above a number of services delivered. Hospitals promote the shift towards value-based medicine by prioritizing preventative care, using technology, and promoting teamwork.
Report Scope
| Feature of the Report | Details |
| Market Size in 2023 | USD 3.9 Billion |
| Projected Market Size in 2032 | USD 20.5 Billion |
| Market Size in 2022 | USD 3.5 Billion |
| CAGR Growth Rate | 7.5% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Model, Deployment Type, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Value-Based Healthcare Market: Regional Analysis
By region, Value-Based Healthcare market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. Europe dominated the global Value-Based Healthcare market in 2022 with a market share of 40% in 2022 and is expected to keep its dominance during the forecast period 2024-2032.
Europe is leading the value-based healthcare business with a variety of programs targeted at improving patient outcomes while reducing costs. One essential solution is to transition from fee-for-service models to outcome-based payment systems, which incentivize healthcare providers to prioritize quality over several treatments.
Furthermore, European nations are investing in cutting-edge technology such as electronic medical records, telemedicine, and remote monitoring of patients to improve care coordination, minimize unnecessary hospitalizations, and increase access to healthcare services, especially for rural communities.
Furthermore, collaboration among healthcare stakeholders, especially governance, insurance companies, providers, and pharmaceutical companies, is promoting the creation of integrated care models and multidisciplinary care teams, providing comprehensive patient management across the continuum of care.
These coordinated efforts highlight Europe’s commitment to promoting value-based healthcare, integrating interests with patient needs.
Value-Based Healthcare Market: Recent Developments
- In January 2023, Edifecs, Inc., a world-renowned health information technology solutions company, and 3M Health Information Systems (HIS) announced a collaboration to combine their leading technologies to offer an innovative solution for both payers and providers that will accelerate the implementation of value-based payment models.
- In May 2023, Siemens Healthineers® and CommonSpirit Health® have reached an agreement to buy Block Imaging®. The recent purchase will give more sustainable alternatives while also meeting the growing need for multi-vendor imaging components that aim to deliver value-based healthcare management of technology solutions.
- In December 2022, Cardinal Health launched Navista TS™ a portfolio of AI-enabled technology solutions to assist oncology clinics enhance patient care, reducing costs, and driving success in value-based care.
List of the prominent players in the Value-Based Healthcare Market:
- Cerner Corporation
- McKesson Corporation
- Siemens Healthier
- UnitedHealth Group
- Philips Healthcare
- IBM Watson Health
- GE Healthcare
- Allscripts Healthcare Solutions Inc.
- Epic Systems Corporation
- Medtronic plc
- CVS Health
- Athenahealth Inc.
- Evolent Health Inc.
- 3M Health Information Systems
- Change Healthcare
- Dexcom Inc.
- Novartis AG
- Merck & Co. Inc.
- Pfizer Inc.
- Johnson & Johnson
- Others
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Value-Based Healthcare Market is segmented as follows:
By Model
- Accountable Care Organization
- Patient-Centered Medical Home
- Pay for Performance
- Bundled Payments
By Deployment Type
- Cloud
- On-premises
By End User
- Hospitals
- Clinics
- Insurance Companies
- Government
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Value-Based Healthcare Market, (2024 – 2033) (USD Billion)
- 2.2 Global Value-Based Healthcare Market: snapshot
- Chapter 3. Global Value-Based Healthcare Market – Industry Analysis
- 3.1 Value-Based Healthcare Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing demand for high-quality health treatment
- 3.2.2 Heightened demand for remote patient monitoring
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Model
- 3.7.2 Market Attractiveness Analysis By Deployment Type
- 3.7.3 Market Attractiveness Analysis By End User
- Chapter 4. Global Value-Based Healthcare Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Value-Based Healthcare Market: Company Market Share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Value-Based Healthcare Market – Model Analysis
- 5.1 Global Value-Based Healthcare Market Overview: By Model
- 5.1.1 Global Value-Based Healthcare Market Share, By Model, 2022 and – 2033
- 5.2 Accountable Care Organization
- 5.2.1 Global Value-Based Healthcare Market by Accountable Care Organization, 2024 – 2033 (USD Billion)
- 5.3 Patient-Centered Medical Home
- 5.3.1 Global Value-Based Healthcare Market by Patient-Centered Medical Home, 2024 – 2033 (USD Billion)
- 5.4 Pay for Performance
- 5.4.1 Global Value-Based Healthcare Market by Pay for Performance, 2024 – 2033 (USD Billion)
- 5.5 Bundled Payments
- 5.5.1 Global Value-Based Healthcare Market by Bundled Payments, 2024 – 2033 (USD Billion)
- 5.1 Global Value-Based Healthcare Market Overview: By Model
- Chapter 6. Global Value-Based Healthcare Market – Deployment Type Analysis
- 6.1 Global Value-Based Healthcare Market Overview: By Deployment Type
- 6.1.1 Global Value-Based Healthcare Market Share, By Deployment Type, 2022 and – 2033
- 6.2 Cloud
- 6.2.1 Global Value-Based Healthcare Market by Cloud, 2024 – 2033 (USD Billion)
- 6.3 On-premises
- 6.3.1 Global Value-Based Healthcare Market by On-premises, 2024 – 2033 (USD Billion)
- 6.1 Global Value-Based Healthcare Market Overview: By Deployment Type
- Chapter 7. Global Value-Based Healthcare Market – End User Analysis
- 7.1 Global Value-Based Healthcare Market Overview: By End User
- 7.1.1 Global Value-Based Healthcare Market Share, By End User, 2022 and – 2033
- 7.2 Hospitals
- 7.2.1 Global Value-Based Healthcare Market by Hospitals, 2024 – 2033 (USD Billion)
- 7.3 Clinics
- 7.3.1 Global Value-Based Healthcare Market by Clinics, 2024 – 2033 (USD Billion)
- 7.4 Insurance Companies
- 7.4.1 Global Value-Based Healthcare Market by Insurance Companies, 2024 – 2033 (USD Billion)
- 7.5 Government
- 7.5.1 Global Value-Based Healthcare Market by Government, 2024 – 2033 (USD Billion)
- 7.6 Others
- 7.6.1 Global Value-Based Healthcare Market by Others, 2024 – 2033 (USD Billion)
- 7.1 Global Value-Based Healthcare Market Overview: By End User
- Chapter 8. Value-Based Healthcare Market – Regional Analysis
- 8.1 Global Value-Based Healthcare Market Regional Overview
- 8.2 Global Value-Based Healthcare Market Share, by Region, 2022 & – 2033 (USD Billion)
- 8.3. North America
- 8.3.1 North America Value-Based Healthcare Market, 2024 – 2033 (USD Billion)
- 8.3.1.1 North America Value-Based Healthcare Market, by Country, 2024 – 2033 (USD Billion)
- 8.3.1 North America Value-Based Healthcare Market, 2024 – 2033 (USD Billion)
- 8.4 North America Value-Based Healthcare Market, by Model, 2024 – 2033
- 8.4.1 North America Value-Based Healthcare Market, by Model, 2024 – 2033 (USD Billion)
- 8.5 North America Value-Based Healthcare Market, by Deployment Type, 2024 – 2033
- 8.5.1 North America Value-Based Healthcare Market, by Deployment Type, 2024 – 2033 (USD Billion)
- 8.6 North America Value-Based Healthcare Market, by End User, 2024 – 2033
- 8.6.1 North America Value-Based Healthcare Market, by End User, 2024 – 2033 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Value-Based Healthcare Market, 2024 – 2033 (USD Billion)
- 8.7.1.1 Europe Value-Based Healthcare Market, by Country, 2024 – 2033 (USD Billion)
- 8.7.1 Europe Value-Based Healthcare Market, 2024 – 2033 (USD Billion)
- 8.8 Europe Value-Based Healthcare Market, by Model, 2024 – 2033
- 8.8.1 Europe Value-Based Healthcare Market, by Model, 2024 – 2033 (USD Billion)
- 8.9 Europe Value-Based Healthcare Market, by Deployment Type, 2024 – 2033
- 8.9.1 Europe Value-Based Healthcare Market, by Deployment Type, 2024 – 2033 (USD Billion)
- 8.10 Europe Value-Based Healthcare Market, by End User, 2024 – 2033
- 8.10.1 Europe Value-Based Healthcare Market, by End User, 2024 – 2033 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Value-Based Healthcare Market, 2024 – 2033 (USD Billion)
- 8.11.1.1 Asia Pacific Value-Based Healthcare Market, by Country, 2024 – 2033 (USD Billion)
- 8.11.1 Asia Pacific Value-Based Healthcare Market, 2024 – 2033 (USD Billion)
- 8.12 Asia Pacific Value-Based Healthcare Market, by Model, 2024 – 2033
- 8.12.1 Asia Pacific Value-Based Healthcare Market, by Model, 2024 – 2033 (USD Billion)
- 8.13 Asia Pacific Value-Based Healthcare Market, by Deployment Type, 2024 – 2033
- 8.13.1 Asia Pacific Value-Based Healthcare Market, by Deployment Type, 2024 – 2033 (USD Billion)
- 8.14 Asia Pacific Value-Based Healthcare Market, by End User, 2024 – 2033
- 8.14.1 Asia Pacific Value-Based Healthcare Market, by End User, 2024 – 2033 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Value-Based Healthcare Market, 2024 – 2033 (USD Billion)
- 8.15.1.1 Latin America Value-Based Healthcare Market, by Country, 2024 – 2033 (USD Billion)
- 8.15.1 Latin America Value-Based Healthcare Market, 2024 – 2033 (USD Billion)
- 8.16 Latin America Value-Based Healthcare Market, by Model, 2024 – 2033
- 8.16.1 Latin America Value-Based Healthcare Market, by Model, 2024 – 2033 (USD Billion)
- 8.17 Latin America Value-Based Healthcare Market, by Deployment Type, 2024 – 2033
- 8.17.1 Latin America Value-Based Healthcare Market, by Deployment Type, 2024 – 2033 (USD Billion)
- 8.18 Latin America Value-Based Healthcare Market, by End User, 2024 – 2033
- 8.18.1 Latin America Value-Based Healthcare Market, by End User, 2024 – 2033 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Value-Based Healthcare Market, 2024 – 2033 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Value-Based Healthcare Market, by Country, 2024 – 2033 (USD Billion)
- 8.19.1 The Middle-East and Africa Value-Based Healthcare Market, 2024 – 2033 (USD Billion)
- 8.20 The Middle-East and Africa Value-Based Healthcare Market, by Model, 2024 – 2033
- 8.20.1 The Middle-East and Africa Value-Based Healthcare Market, by Model, 2024 – 2033 (USD Billion)
- 8.21 The Middle-East and Africa Value-Based Healthcare Market, by Deployment Type, 2024 – 2033
- 8.21.1 The Middle-East and Africa Value-Based Healthcare Market, by Deployment Type, 2024 – 2033 (USD Billion)
- 8.22 The Middle-East and Africa Value-Based Healthcare Market, by End User, 2024 – 2033
- 8.22.1 The Middle-East and Africa Value-Based Healthcare Market, by End User, 2024 – 2033 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Cerner Corporation
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 McKesson Corporation
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Siemens Healthier
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 UnitedHealth Group
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Philips Healthcare
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 IBM Watson Health
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 GE Healthcare
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Allscripts Healthcare Solutions Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Epic Systems Corporation
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Medtronic plc
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 CVS Health
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Athenahealth Inc.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Evolent Health Inc.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 3M Health Information Systems
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Change Healthcare
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Dexcom Inc.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Novartis AG
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Merck & Co. Inc.
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Pfizer Inc.
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Johnson & Johnson
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Cerner Corporation
List Of Figures
Figures No 1 to 27
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2032
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Cerner Corporation
- McKesson Corporation
- Siemens Healthier
- UnitedHealth Group
- Philips Healthcare
- IBM Watson Health
- GE Healthcare
- Allscripts Healthcare Solutions Inc.
- Epic Systems Corporation
- Medtronic plc
- CVS Health
- Athenahealth Inc.
- Evolent Health Inc.
- 3M Health Information Systems
- Change Healthcare
- Dexcom Inc.
- Novartis AG
- Merck & Co. Inc.
- Pfizer Inc.
- Johnson & Johnson
- Others
FAQs
The restraints of the Value-Based Healthcare market is balancing reimbursement and payment mechanisms.
The major driver for the Value-Based Healthcare market is increasing demand for high-quality health treatment and heightened demand for remote patient monitoring.
The “Accountable Care Organization” category dominated the market in 2022.
The key players in the market are Cerner Corporation, McKesson Corporation, Siemens Healthier, UnitedHealth Group, Philips Healthcare, IBM Watson Health, GE Healthcare, Allscripts Healthcare Solutions Inc., Epic Systems Corporation, Medtronic plc, CVS Health, Athenahealth Inc., Evolent Health Inc., 3M Health Information Systems, Change Healthcare, Dexcom Inc., Novartis AG, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson, Others.
“Europe” had the largest share in the Value-Based Healthcare Market.
The global market is projected to grow at a CAGR of 7.5% during the forecast period, 2023-2032.
The Value-Based Healthcare Market size was valued at USD 3.9 Billion in 2023.